Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Enzyme Replacement Agent
DRUG
3 trials
Sponsors
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
, Hasan Kalyoncu University
, AVROBIO
Conditions
Gaucher Disease, Type 3
Late Onset Pompe Disease
Mucopolysaccharidosis
Pompe Disease
Phase 2
An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Withdrawn
NCT05815004
AVROBIO
Gaucher Disease, Type 3
Start: 2023-10-31
End: 2027-12-31
Updated: 2023-08-09
Unknown Phase
Search for Serum/Plasma Biomarkers in Pompe's Disease
NCT03045042
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Late Onset Pompe Disease, Pompe Disease
Start: 2017-04-30
End: 2019-01-31
Target: 35
Updated: 2017-03-20
The Effect of Enzyme Replacement Therapy in Mucopolysaccharidosis
Completed
NCT05006222
Hasan Kalyoncu University
Mucopolysaccharidosis
Start: 2020-02-01
End: 2021-03-27
Updated: 2021-08-16
Related Papers
Identification of serum microRNAs as potential biomarkers in Pompe disease
Annals of Clinical and Translational Neurology
2019-06-12
27 citations